Costain Group PLC
18 September 2003
COSTAIN GROUP PLC
('Costain' or the 'Group')
Principal Supply Chain Partner for NHS Estates Procure 21 national roll-out
Costain is pleased to announce that ACM Health Solutions, its joint partnership
with AMEC and Mowlem, has been selected by NHS Estates as Principal Supply Chain
Partner for the national NHS ProCure 21 framework agreement.
The decision to implement ProCure 21 on a national basis follows the success of
the initial pilot scheme in the North-West and Midlands, in which Costain is
already responsible for several ProCure 21 projects, including the Ormskirk
Hospital in Southport.
NHS Estates has announced a total of 12 Principal Supply Chain Partners for the
national programme, estimated to be worth £7 billion over a five year period,
and covering a wide variety of projects including new hospitals and provision of
additional facilities at existing accommodation.
Peter Woolliscroft, Head of Construction at NHS Estates and Project Director for
NHS ProCure 21 said:
'By working together with the NHS and the private sector, we have been able to
show that the NHS can achieve the types of benefits we have seen the private
sector secure - time, value, predictability and a greater understanding of the
NHS's needs. Patients, staff and the NHS as a whole will now be able to obtain
the benefits that the pilots have demonstrated.'
Chris Strong, ACM Health Solutions General Manager, said:
'ACM has the resource and experience which one would expect from three of the
UK's leading companies. In addition, Costain has played a leading role in the
local ProCure 21 programme and we will capitalise on that vital experience in
the future.
'We look forward to continue working with NHS Estates and ensuring ACM provides
a first-class service throughout the programme.'
18 September 2003
ENQUIRIES:
Costain Group PLC Tel: 01628 842444
Stuart Doughty, Chief Executive
Graham Read, Public Relations
College Hill Tel: 020 7457 2020
Mark Garraway
Matthew Gregorowski
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.